Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/1/17 → … |
Funding
- Investigator Initiate Trial Support: $900,000.00
Phase I/II trial of combination tumor treating fields, nivolumab plus/minus ipilimumab for bevacizumab-naïve, recurrent glioblastoma
- Odia, Yazmin (PI)
Project: Research project